Marc Tessier-Lavigne, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 5,000 shares at $593.64 ($3.0M) on 2015-08-05, disclosed to the SEC on 2015-08-05.
Open-market sale of $3.0M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $584.07 | 1,500 | $876K | 29.7% |
| 2 | $590.17 | 1,000 | $590K | 20.0% |
| 3 | $593.64 | 2,000 | $1.2M | 40.2% |
| 4 | $595.44 | 500 | $298K | 10.1% |
| Total | $590.25 avg | 5,000 | $3.0M | 100% |
| Filing → |
| REGN | SELL | 2022-10-03 | $10.2M | — | Filing → |
| DNLI | SELL | 2022-09-30 | $1.2M | — | Filing → |
| DNLI | SELL | 2022-08-25 | $632K | — | Filing → |